Stepped Palliative Care Versus Early Integrated Palliative Care in Patients With Advanced Lung Cancer
| 対象疾患 | Lung Cancer |
|---|---|
| 相 | 該当なし |
| スポンサー | Massachusetts General Hospital |
| ステータス | 完了 |
| 参加者数 | 507 名 |
| 介入（薬剤） | Stepped PC, Early Integrated PC |
| 開始日 | 2018年2月1日 |
| 完了日 | 2023年7月1日 |
| 結果公開日 | 2024年9月3日 |
概要
This research study is evaluating ways to provide palliative care to patients who have recently been diagnosed with lung cancer
Patient-reported Quality of Life
| Stepped PC | 100.62 score on a scale |
|---|---|
| Early Integrated PC | 97.75 score on a scale |
| p-value | <0.05 |
|---|---|
| Mean Difference (Final Values) | 2.9 |
BENITIONS で見る ClinicalTrials.gov の原文を見る
同じ疾患の他の治験
- Risk and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer — M.D. Anderson Cancer Center
- Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tum — National Cancer Institute (NCI)
- Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients W — National Cancer Institute (NCI)
- A Global Study to Assess the Effects of Osimertinib Following Chemoradiation in Patients W — AstraZeneca
- Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therap — National Cancer Institute (NCI)
- Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With — National Cancer Institute (NCI)